Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia

NCT00249899 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00249899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2005
Completion date
March 31, 2007
Enrollment
649 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia